Re-training and switching of PD system to reduce recurrent gram-positive PD peritonitis

Journal of Renal Care

Volumn 32, Issue 4, 2006, Pages 198-201

  Cox, Sue D ^a   Steddon, S ^a   Mallinder, S ^a   Fan, S L S ^a   Punzalan, Sally ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Peritoneal dialysis; Peritonitis; Touch contamination; UV flash compact

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHRONIC KIDNEY FAILURE; CROSS INFECTION; EQUIPMENT; FEMALE; HUMAN; INFECTION CONTROL; INSTRUMENTATION; MALE; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONITIS; RECURRENT DISEASE; RISK FACTOR; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; EQUIPMENT CONTAMINATION; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; KIDNEY FAILURE, CHRONIC; LONDON; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONITIS; RECURRENCE; RISK FACTORS;

EID: 34247232641     PISSN: 1019083X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2006.tb00022.x     Document Type: Article

References (15)

1. Blake PG. Integrated end-stage renal disease care: the role of peritoneal dialysis. Nephrol Dial Transplant 2005; 16 Suppl 5:61-66.
2. Chow KM, Szeto CC, Leung U, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005, 25:374-379.
3. Perez FM, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005, 25:274-284.
4. Anonymous. Treatment of adult patients with renal failure: recommended standards and audit measures. The Standards and Audit Subcommittee of the Renal Association on behalf of the Renal Association and the Royal College of Physicians. J R.Coll Physicians. London 1995; 29:190-1911.
5. Bazzato G, Landini S, Fracasso A, Morachiello P, Righetto F, Scanferla F, et al. Why the double-bag system still remains the best technique for peritoneal fluid exchange in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993 13 Suppl 2:S152-S155
6. Lauder SM, Zappacosta AR. Components of a successful CAPD education program. ANNA J 1988; 15:243-247.
7. Wong G. Post training follow-up: a critical component for CAPID success. AANNT.J 1982; 9:33-5, 69.
8. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27:695-700.
9. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18:261-270.
10. Uttley L, Vardhan A, Mahajan S, Smart B, Hutchison A, Gokal R. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. J Nephrol 2004, 17:242-245.
11. Durand PY, Chanliau J, Gamberoni J, Mariot A, Kessler M. UV-flash: clinical evaluation in 97 patients; results of a French multicenter trial. Perit Dial Int 1994; 14:86-89.
12. Nakamuro Y, Hara Y, Ishida H, Moriwaki K, Shigemoto K. A randomized multicenter trial to evaluate the effects of UV-Flash system on peritonitis rates in CAPD. Adv.Perit Dial 1992; 8:313-315.
13. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Sac Nephrol 2005; 16:539-545.
14. Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000; 20:516-523.
15. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005; 25:248-255.